Microsoft Word - 151201_Press Release_Eg_FINAL.docx


Astellas Announces Personnel Change


Tokyo, December 1, 2015 - Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka) today announced the personnel change as below.


1. Personnel change of an affiliate effective December 8, 2015


Name

New Title

Current Title


Toshihiro Watanabe

President,

Astellas Research Technologies Co., Ltd.

Drug Discovery Research,

Astellas Pharma Inc.


About Astellas

Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. We focus on Urology, Oncology, Immunology, Nephrology and Neuroscience as prioritized therapeutic areas while advancing new therapeutic areas and discovery research leveraging new technologies/modalities. We are also creating new value by combining internal capabilities and external expertise in the medical/healthcare business. Astellas is on the forefront of healthcare change to turn innovative science into value for patients. For more information, please visit our website at www.astellas.com/en.


###


Contacts for inquiries or additional information Astellas Pharma Inc.

Corporate Communications

TEL: 03-3244-3201 FAX: 03-5201-7473

http://www.astellas.com/en



distributed by